ERN1 and neoplasm: In glioblastoma where IRE1 somatic mutations have been linked to shorter patient survival, the IRE1 signaling dictates two distinct tumor phenotypes, with XBP1s driving the protumorigenic program, while RIDD activity attenuates it [121].